Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

bivalirudin for injection - ADD-VANTAGE Principal Display Panel

PRINCIPAL DISPLAY PANEL - 250 mg Vial Label

Single-dose ADD-Vantage™ Vial

Bivalirudin
For Injection
250 mg/vial

INTRAVENOUS USE ONLY

WARNING: This package is
intended for institutional
use only.

PRINCIPAL DISPLAY PANEL - 250 mg Vial Label

PRINCIPAL DISPLAY PANEL - 250 mg Vial Box

10 x 250 mg Single-dose
ADD-Vantage™ Vials

NDC 0409-8300-15
Contains 10 of NDC 0409-8300-25

Rx only

Bivalirudin For Injection
250 mg/vial

INTRAVENOUS USE ONLY
WARNING: This package is intended for institutional use only.

Hospira

PRINCIPAL DISPLAY PANEL - 250 mg Vial Box
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event